Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Qiagen to Increase Safety of Blood Donations in Brazil

By LabMedica International staff writers
Posted on 09 Jun 2009
Qiagen (Frankfurt, Germany) has entered into an agreement to supply molecular sample and assay technologies for a new national, polymerase chain reaction (PCR)-based blood screening program for human immunodeficiency virus (HIV) and Hepatitis C (HCV) in Brazil. More...


The company will provide Bio-Manguinhos (Rio de Janeiro, Brazil), the main provider of vaccines and diagnostics to the Brazilian Ministry of Health, with molecular testing solutions, sample and assay technologies, instrumentation, operational know-how, and training. The agreement will run for five years and contains options for subsequent extensions.

Qiagen's extraction and testing components will be included in the screening kits and sold in a format featuring Bio-Manguinhos's name and branding. The kits will run on a high-throughput multiplex PCR platform, which allows processing of large numbers of samples and detecting multiple pathogens in a single run. The highly automated platform, which includes an advanced control system based on biosafe viruses developed by Bio-Manguinhos, been validated in the field.

Brazil's new national screening program is scheduled to start in 2010. Every year, five million blood donations are performed in Brazil (population--190 million), of which 70% are conducted by public blood banks. Approximately 0.1% and 0.3% of these donations are tested positive for HIV and HCV, respectively, using older, less sensitive serological methods. It is believed that the real percent of positives could be significantly higher.

Peer M. Schatz, CEO of Qiagen said, "We are proud to team up with the Brazilian authorities in a combined effort to significantly reduce the number of blood-borne transmissions of HIV and HCV and the resulting disease burden."

Bio-Manguinhos is one of the official laboratories of the Brazilian Ministry of Health. The unit supports disease prevention policies, epidemiologic programs, sanitation, and surveillance in the immunobiologic area.

Qiagen is a global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA, and proteins from biologic samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible.

Related Links:

Qiagen
Bio-Manguinhos
Ministry of Health, Brazil



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Radial Immunodiffusion Assay
Radial Immunodifusion - C3 ID
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.